BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 10352254)

  • 1. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of Ly49 expression on CD4+ and CD4-CD8- (double negative) NK1.1+ T cells.
    Sköld M; Cardell S
    Eur J Immunol; 2000 Sep; 30(9):2488-96. PubMed ID: 11009081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
    Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice.
    Eberl G; Lowin-Kropf B; MacDonald HR
    J Immunol; 1999 Oct; 163(8):4091-4. PubMed ID: 10510341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus.
    Zeng D; Gazit G; Dejbakhsh-Jones S; Balk SP; Snapper S; Taniguchi M; Strober S
    J Immunol; 1999 Nov; 163(10):5338-45. PubMed ID: 10553057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.
    Stenström M; Sköld M; Andersson A; Cardell SL
    Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells.
    Hameg A; Gouarin C; Gombert JM; Hong S; Van Kaer L; Bach JF; Herbelin A
    J Immunol; 1999 Jun; 162(12):7067-74. PubMed ID: 10358149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.
    Stenström M; Sköld M; Ericsson A; Beaudoin L; Sidobre S; Kronenberg M; Lehuen A; Cardell S
    Eur J Immunol; 2004 Jan; 34(1):56-65. PubMed ID: 14971030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.
    Schulz RJ; Parkes A; Mizoguchi E; Bhan AK; Koyasu S
    J Immunol; 1996 Nov; 157(10):4379-89. PubMed ID: 8906813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer-like T cells develop in SJL mice despite genetically distinct defects in NK1.1 expression and in inducible interleukin-4 production.
    Beutner U; Launois P; Ohteki T; Louis JA; MacDonald HR
    Eur J Immunol; 1997 Apr; 27(4):928-34. PubMed ID: 9130646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
    Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
    J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
    Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
    J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of NKT cell differentiation by tissue-specific microenvironments.
    Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
    J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-associated rapid and Stat6-independent IL-4 production by NK1-CD4+8- thymus T lymphocytes.
    Chen YT; Chen FL; Kung JT
    J Immunol; 1999 Nov; 163(9):4747-53. PubMed ID: 10528173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology. T before NK.
    MacDonald HR
    Science; 2002 Apr; 296(5567):481-2. PubMed ID: 11964466
    [No Abstract]   [Full Text] [Related]  

  • 20. CD1d-restricted NKT cells: an interstrain comparison.
    Hammond KJ; Pellicci DG; Poulton LD; Naidenko OV; Scalzo AA; Baxter AG; Godfrey DI
    J Immunol; 2001 Aug; 167(3):1164-73. PubMed ID: 11466330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.